|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/23 | (2006.01) |
| A01N 37/02 | (2006.01) | ||
| A01N 37/06 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/00 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 3/08 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3445354 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17786579.7 |
| Date of filing the European patent application | 2017-04-19 | |
| (97) | Date of publication of the European application | 2019-02-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-25 |
| (46) | Date of publication of the claims translation | 2022-09-12 |
| (86) | Number | PCT/US2017/028417 |
| Date | 2017-04-19 |
| (87) | Number | WO 2017/184767 |
| Date | 2017-10-26 |
| (30) | Number | Date | Country code |
| 201662325381 P | 2016-04-20 | US |
| (72) |
STREEPER, Robert T. , US
IZBICKA, Elzbieta , US
|
| (73) |
New Frontier Labs, LLC ,
900 NE Loop 410, Suite D-119, San Antonio, TX 78209-1403,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Azelaino rūgšties esteriai, naudojami gydant atsparumą insulinui |
| AZELAIC ACID ESTERS IN THE TREATMENT OF INSULIN RESISTANCE |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 10 | 231.00 EUR |
| 2027-04-19 |